ARTICLE
23 October 2023

Propsci Perspectives: JLL

GP
Goodwin Procter LLP

Contributor

At Goodwin, we partner with our clients to practice law with integrity, ingenuity, agility, and ambition. Our 1,600 lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigation and world-class advisory services in the technology, life sciences, real estate, private equity, and financial industries. Our unique combination of deep experience serving both the innovators and investors in a rapidly changing, technology-driven economy sets us apart.
The Goodwin Propsci team has partnered with several well-known companies for a short video series that explores what's happening in the real estate life sciences industry.
United States Real Estate and Construction
To print this article, all you need is to be registered or login on Mondaq.com.

The Goodwin Propsci team has partnered with several well-known companies for a short video series that explores what's happening in the real estate life sciences industry.

In our latest installment, Bob Coughlin, Managing Director of Life Sciences and Healthcare at JLL, joins Nicole Riley for a thought-provoking discussion. JLL is a real estate and investment management company that provides services to real estate investors and occupiers. JLL's Life Sciences team helps fast-growing biotech, pharmaceutical, medical devices, and medtech organizations.

To view the full article please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More